Cladribine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2865 publications

A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.

A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.

Journal: Neurodegenerative disease management

Published: April 07, 2026

The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage.

The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage.

Journal: Journal of visualized experiments : JoVE

Published: March 23, 2026

Portuguese consensus for the use of cladribine tablets in multiple sclerosis.

Portuguese consensus for the use of cladribine tablets in multiple sclerosis.

Journal: Neurodegenerative disease management

Published: March 23, 2026

Comment on "Cost-effectiveness analysis of high-efficacy drugs used in the treatment of multiple sclerosis in a large health insurance provider in Brazil".

Comment on "Cost-effectiveness analysis of high-efficacy drugs used in the treatment of multiple sclerosis in a large health insurance provider in Brazil".

Journal: Journal of the neurological sciences

Published: March 13, 2026

Immune-related enteropathy.

Immune-related enteropathy.

Journal: Current opinion in gastroenterology

Published: March 05, 2026

Authors response to Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis".

Authors response to Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis".

Journal: Journal of the neurological sciences

Published: February 09, 2026

Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis".

Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis".

Journal: Journal of the neurological sciences

Published: January 29, 2026

Cladribine for people with multiple sclerosis.

Cladribine for people with multiple sclerosis.

Journal: The Cochrane database of systematic reviews

Published: January 09, 2026

Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis

Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis

Journal: Zhongguo shi yan xue ye xue za zhi

Published: January 08, 2026

Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study.

Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study.

Journal: Frontiers in neurology

Published: January 08, 2026

Aggressive Systemic Mastocytosis Presenting as Diffuse Osteoblastic Bone Disease: A Diagnostic Pitfall Mimicking Metastatic Cancer.

Aggressive Systemic Mastocytosis Presenting as Diffuse Osteoblastic Bone Disease: A Diagnostic Pitfall Mimicking Metastatic Cancer.

Journal: European journal of case reports in internal medicine

Published: January 04, 2026

Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment.

Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment.

Journal: Clinical immunology (Orlando, Fla.)

Published: December 29, 2025

Showing 1-12 of 2,865

Last Updated: 04/28/2026